Home › Funds › SJBENEN ADVISORY, LLC › NRXP

SJBENEN ADVISORY, LLC position in NRXP

NRX Pharmaceuticals Inc · Health Care

SJBENEN ADVISORY, LLC reported holding 15,000 shares of NRXP (NRX Pharmaceuticals Inc) in its Q3 2026 13F filing — a position valued at US$42K, representing 0.03% of its reported portfolio and ranking #29 among its reported holdings. SJBENEN ADVISORY, LLC has disclosed NRXP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)15.00K sh
Reported value held$41.98K
Portfolio Weight0.03%
First reportedQ4 2025
Last changeHold
Updated2026-10-19

Last updated: 2026-10-19 · Source: SEC EDGAR Form 13F-HR

How SJBENEN ADVISORY, LLC's NRXP position evolved

SJBENEN ADVISORY, LLC first disclosed a stake in NRXP in Q4 2025 at 15,000 shares (US$41K). The position peaked in Q2 2026 at 15,000 shares, worth US$58K. Across 4 filings, SJBENEN ADVISORY, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 15,000 shares valued at US$42K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 15.00K $40.65K New
Q1 2026 15.00K $31.95K Hold
Q2 2026 15.00K $57.75K Hold
Q3 2026 15.00K $41.98K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRXP and 13F data

NRXP (NRX Pharmaceuticals Inc) is a Health Care company. 47 other funds we track also report a position in NRXP — the largest reported positions include B Group, Inc. (US$16.7M), AdvisorShares Investments LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRXP

All NRXP fund holders →

FAQ

How long has SJBENEN ADVISORY, LLC held NRXP?

SJBENEN ADVISORY, LLC has disclosed NRXP holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is SJBENEN ADVISORY, LLC's current position in NRXP?

As of Q3 2026, SJBENEN ADVISORY, LLC holds 15.00K shares of NRXP (NRX Pharmaceuticals Inc), valued at $41.98K, representing 0.03% of its reported portfolio and ranking #29.

Has SJBENEN ADVISORY, LLC been buying or selling NRXP?

In the latest 13F filing (Q3 2026), SJBENEN ADVISORY, LLC held unchanged its position in NRXP. The position peaked in Q2 2026 at 15.00K shares.

Which other funds hold NRXP?

Other major institutional holders of NRXP include B Group, Inc., AdvisorShares Investments LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.